DNLI
Denali Therapeutics Inc.
$15.27
-$0.38(-2.43%)
42
Overall
--
Value
40
Tech
44
Quality
Market Cap
$2.27B
Volume
1.89M
52W Range
$10.57 - $33.33
Target Price
$32.20
Key Metrics Overview
| Market Cap | $2.27B | P/E Ratio | N/A |
| 52W High | $33.33 | 52W Low | $10.57 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -1.8% | 52W Position | 20.7% |
| Overall Score | 42 | Value Score | -- |
| Quality Score | 44 | Technical Score | 40 |
Growth Analysis
| EPS Current Est | $-3.05 | EPS Next Est | $-2.94 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNLI | $15.27 | -2.4% | 1.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Denali Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW